EGFR and lung carcinoma: Deletion in exon 19 and a single point mutation in exon 21 prompt the generation of EGFR tyrosine kinase inhibitor, results in exhaustive NSCLC cell proliferation, being the precursor for the spread of lung cancer cells in human.